Mesenchymal Stem Cells Treatment Aggravates Tumor Growth Regardless Its Route of Administration: An In vivo Study
to clarify the effect of MSCs in cancer growth and to detect whether the rout of administration (either locally inside the tumor tissue or systemic )could affect the outcome of treatment or not. Eighteen female mice were involved in the study. All mice were subcutaneously inoculated with Ehrlich tum...
Saved in:
Published in | Asian Pacific journal of cancer prevention : APJCP Vol. 23; no. 10; pp. 3309 - 3315 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Thailand
West Asia Organization for Cancer Prevention
01.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | to clarify the effect of MSCs in cancer growth and to detect whether the rout of administration (either locally inside the tumor tissue or systemic )could affect the outcome of treatment or not.
Eighteen female mice were involved in the study. All mice were subcutaneously inoculated with Ehrlich tumor cells into the right flank. After three week of tumor growth; the mice were divided randomly in to three groups six mice for each ; group I: untreated Erlish tumor group; group II: Erlish tumor treated by local injection of 1 x106 MSCs/week inside the tumor tissue, group III: Erlish tumor treated by systemic injection of 1 x106 MSCs iv in tail vein/week. Tumor growth was recorded .After 4 weeks of stem cells injection, all rats were sacrificed by cervical dislocation and tumor tissues were collected for histopathological study. inflammatory cytokine TNF was assessed by ELISA, lncRNA MALAT ,NFKB and MMP2 genes expression were assessed by Quantitative RT-PCR.
Erlish tumor was developed as a well-defined capsule composed by connective tissue infiltrated by inflammatory and neoplastic cells surrounded the tumors. The tumor growth regarding size and weight of tumor tissue was significantly aggravated after both local and systemic treatment MSCs (p value =0.007, 0.001) respectively. Inflammatory cytokines TNF and NFKB were significantly elevated (p value <0.0001), lncRNA MALAT, MMP2 expressions were significantly induced (p value <0.0001), after MSCs treatment with more significant increase in those treated by local intratumor injection of MSCs compared to those treated by systemic MSCs(p value <0.0001).
Ehrlich tumor model is feasible and easily monitored tumor model. Although MSCs have anti-inflammatory effect and the ability to regenerate the damaged tissue; it could aggravate tumor growth as it exploited by cancer cells for behave of tumor cells. |
---|---|
AbstractList | to clarify the effect of MSCs in cancer growth and to detect whether the rout of administration (either locally inside the tumor tissue or systemic )could affect the outcome of treatment or not.
Eighteen female mice were involved in the study. All mice were subcutaneously inoculated with Ehrlich tumor cells into the right flank. After three week of tumor growth; the mice were divided randomly in to three groups six mice for each ; group I: untreated Erlish tumor group; group II: Erlish tumor treated by local injection of 1 x106 MSCs/week inside the tumor tissue, group III: Erlish tumor treated by systemic injection of 1 x106 MSCs iv in tail vein/week. Tumor growth was recorded .After 4 weeks of stem cells injection, all rats were sacrificed by cervical dislocation and tumor tissues were collected for histopathological study. inflammatory cytokine TNF was assessed by ELISA, lncRNA MALAT ,NFKB and MMP2 genes expression were assessed by Quantitative RT-PCR.
Erlish tumor was developed as a well-defined capsule composed by connective tissue infiltrated by inflammatory and neoplastic cells surrounded the tumors. The tumor growth regarding size and weight of tumor tissue was significantly aggravated after both local and systemic treatment MSCs (p value =0.007, 0.001) respectively. Inflammatory cytokines TNF and NFKB were significantly elevated (p value <0.0001), lncRNA MALAT, MMP2 expressions were significantly induced (p value <0.0001), after MSCs treatment with more significant increase in those treated by local intratumor injection of MSCs compared to those treated by systemic MSCs(p value <0.0001).
Ehrlich tumor model is feasible and easily monitored tumor model. Although MSCs have anti-inflammatory effect and the ability to regenerate the damaged tissue; it could aggravate tumor growth as it exploited by cancer cells for behave of tumor cells. |
Author | Mostafa, Abeer Mohamed Abdelsalam, Shimaa Mekawey, Dina S Sabbah, W |
AuthorAffiliation | 1 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt 2 Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt 3 Department of Anatomy, Faculty of Medicine for girls, Al Azhar University, Egypt |
AuthorAffiliation_xml | – name: 3 Department of Anatomy, Faculty of Medicine for girls, Al Azhar University, Egypt – name: 1 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt – name: 2 Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt |
Author_xml | – sequence: 1 givenname: Abeer orcidid: 0000-0002-3034-3835 surname: Mostafa fullname: Mostafa, Abeer organization: Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt – sequence: 2 givenname: Shimaa surname: Mohamed Abdelsalam fullname: Mohamed Abdelsalam, Shimaa organization: Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt – sequence: 3 givenname: W surname: S Sabbah fullname: S Sabbah, W organization: Department of Anatomy, Faculty of Medicine for girls, Al Azhar University, Egypt – sequence: 4 givenname: Dina surname: Mekawey fullname: Mekawey, Dina organization: Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36308353$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkFtLwzAcxYNM3EW_wsgX6MylaVofhDJ0TiaOOcG3kjX_bZU2mUk22be34gV9OnAO5wfn9FHHWAMIDSkZcSqEvMzn9-P5iBHGRoyPPm1OshPUY7FMIpmwlw7qUUF5JHmSdlHf-1dCYpFKcYa6POEk5YL30NsDeDDl9tioGj8FaPAY6trjpQMVGjAB55uNUwcVoDX3jXV44ux72OIFbJTTNXiPp8Hjhd0HwHaNc91UpvLBqVBZc4Vzg6cGH6qDbfl7fTxHp2tVe7j41gF6vr1Zju-i2eNkOs5nUclIkkXrWFApeCl0minSjuIrGdNEyxIyKDXJKAUmV4LTjIBOATQRUlNYtQesBVV8gK6_uLv9qgFdtlucqoudqxrljoVVVfE_MdW22NhDkWUs5jFtAcO_gN_mz3n8A6Ycdu8 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 5PM |
DOI | 10.31557/APJCP.2022.23.10.3309 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2476-762X |
EndPage | 3315 |
ExternalDocumentID | 36308353 |
Genre | Journal Article |
GroupedDBID | CGR CUY CVF ECM EIF NPM --- 23N 2WC 53G 5GY 5PM 9ZL ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK E3Z EBS EJD F5P FRJ GROUPED_DOAJ GX1 HYE JDI OK1 RPM TR2 W2D WOW |
ID | FETCH-LOGICAL-c2069-f451753c5d89a04763b7416d7ce9ecd0911e27b53190ed8eed057d1eb247f51a3 |
IEDL.DBID | RPM |
ISSN | 1513-7368 |
IngestDate | Tue Apr 09 21:57:11 EDT 2024 Sat Feb 18 14:24:09 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Erlish MSCs MMP2 and TNF lncRNA MALAT |
Language | English |
License | This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2069-f451753c5d89a04763b7416d7ce9ecd0911e27b53190ed8eed057d1eb247f51a3 |
ORCID | 0000-0002-3034-3835 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924341/ |
PMID | 36308353 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9924341 pubmed_primary_36308353 |
PublicationCentury | 2000 |
PublicationDate | 2022-Oct-01 20221001 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-Oct-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Thailand |
PublicationPlace_xml | – name: Thailand – name: Iran |
PublicationTitle | Asian Pacific journal of cancer prevention : APJCP |
PublicationTitleAlternate | Asian Pac J Cancer Prev |
PublicationYear | 2022 |
Publisher | West Asia Organization for Cancer Prevention |
Publisher_xml | – name: West Asia Organization for Cancer Prevention |
SSID | ssj0045875 |
Score | 2.3655903 |
Snippet | to clarify the effect of MSCs in cancer growth and to detect whether the rout of administration (either locally inside the tumor tissue or systemic )could... |
SourceID | pubmedcentral pubmed |
SourceType | Open Access Repository Index Database |
StartPage | 3309 |
SubjectTerms | Animals Cytokines - metabolism Female Matrix Metalloproteinase 2 - metabolism Mesenchymal Stem Cell Transplantation Mesenchymal Stem Cells Mice Rats RNA, Long Noncoding - metabolism |
Title | Mesenchymal Stem Cells Treatment Aggravates Tumor Growth Regardless Its Route of Administration: An In vivo Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36308353 https://pubmed.ncbi.nlm.nih.gov/PMC9924341 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb4IwFG6ch2WXZb_nfqWHXRGkLYXdjNkvE4zZXLKbgfahJoJO2RL_-72CLHLdhQMUAm157_vS730l5N4TMZNcRBZSZWVxJR0rcgAsHSVRxLUHcbFLRDjwXj54_1N8NoioamEK0b6KZ-1snraz2bTQVi5TZVc6MXsY9gIkDRh97T2yJxmrKHoZfrnwC3ddzGTMkszzy7JghnlT2t1hvzdEUui6bZe1zWnmGN9Q5jEDRdhOGqpLJHdyztMROdyCRdotX-qYNCA7Ifvhdjn8lHyFpnZITTcptnrPIaU9mM_XdFSpx2l3YvYXMniSjr7TxYo-I-3Op_QNJjg18EPX9DVfU6MLArpIaN1L94F2M_qa0Z_Zz4IaxeHmjHw8PY56L9Z2DwVLuY4XWAkXxotTCe0HkcMxmsQGg2mpIAClES10wJWx-RMd0D5mTARwuoN8m8tEdCJ2TprZIoNLQpnSbof5IgKpeOLqALlGEMQJ-PgAcIMWuSj7bLwsjTLGVbe2iKz15l8D421dv4JDXnhcb4f46t93XpMDM86l7u6GNPPVN9wifsjju4J343EwDO-KufMLW6DH9Q |
link.rule.ids | 230,315,733,786,790,870,891,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFL1qi0TZAKUUyquzYGvHmYfHZhdFlKTUVVTSqrvInrluImKnNE6l8vXcseOqYQdbz_g1r3uO5twzAJ9DlQktVeoRVTaeNDrw0gDRs2meptKGmNWnRCRn4eBCnlypqy1QbS5MLdo32cwv54Vfzqa1tvKmMJ1WJ9YZJf2YSAOtvp1teELzlauWpDcLsFRR7a9LsUx4WoRRkxgsKHLqTm900h8RLeTc58J3l0XgnENFKBwYEY8C0aZI8lHUOX4Bl-33NmKTn_6qynzz-y8rx3_-oZfwfI1DWa8p3oMtLF_B02S9074PvxKXlmSm9wXV-lFhwfo4ny_ZuBWms961O7rIQVU2XhWLW_aNGH01Zed4TaOOXrlkw2rJnOQI2SJnmza9X1ivZMOS3c3uFsyJGe9fw8Xx13F_4K2PZ_AMD8LYy6VyNp9G2ShOA0kLVebgndUGYzSWgEgXuc7cJA_QRhSMCRvaLlF5qXPVTcUB7JSLEt8CE8byrohUitrInNuYaEwcZzlG9ADk8SG8aTpjctN4cEza_joEvdFNDxWcbfZmCTV-bZ-9bux3_33nEewOxsnp5HR49v09PHODqZH3fYCd6naFHwmmVNmnelD-AftR5-o |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dT9swFLUGkxAvjPHN2OYHXvNR24mTvVXdOsooqqBIiJcqtm_aiiYtNEViv37XSYPaPfKaOMrHvfY9Rzk-l5DzMFBciiBxkCprR2jpO4kP4JgkTRJhQlBll4judXhxJy7vg_uVVl-laF-rsZtPMjcfj0pt5SzTXq0T83rdVoykAVdfb2ZSb4N8xDnLZE3Uq0VYBFHpsYv1jDuSh1G1OZhj9ZRes3fZ6iE1ZMxl3LWHuW_dQ3nILSDhK8VoXSi5Unnan8hD_cyV4OTRXRTK1X__s3N810vtkp0lHqXNashn8gHyPbLVXf5x3ydPXbs9SY9eMxx1W0BGWzCZzGm_FqjT5tC2MLKQlfYX2fSZ_kZmX4zoDQwx-_C2c9op5tRKj4BOU7pu1_uDNnPayenL-GVKrajx9YDctX_1WxfOsk2Do5kfxk4qAmv3qQMTxYkvcMFSFuYZqSEGbRCQNIBJZSe7DybCoowY0TSQ0guZBo2EH5LNfJrDMaFcG9bgUZCA1CJlJkY6E8cqBQywAhafkKMqIINZ5cUxqGN2QuRaqN4GWPvs9TMYgNJGe_nBT9995Xey1fvZHlx1rv98Ids2nyqV3xnZLJ4X8BXRSqG-lXn5D02u6mo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+Stem+Cells+Treatment+Aggravates+Tumor+Growth+Regardless+Its+Route+of+Administration%3A+An+In+vivo+Study&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Mostafa%2C+Abeer&rft.au=Abdelsalam%2C+Shimaa+Mohamed&rft.au=Sabbah%2C+W+.S.&rft.au=Mekawey%2C+Dina&rft.date=2022-10-01&rft.pub=West+Asia+Organization+for+Cancer+Prevention&rft.issn=1513-7368&rft.eissn=2476-762X&rft.volume=23&rft.issue=10&rft.spage=3309&rft.epage=3315&rft_id=info:doi/10.31557%2FAPJCP.2022.23.10.3309&rft_id=info%3Apmid%2F36308353&rft.externalDBID=PMC9924341 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon |